Published in Antioxid Redox Signal on June 19, 2013
Elusive roles for reactive astrocytes in neurodegenerative diseases. Front Cell Neurosci (2015) 0.95
The effects of the β-lactam antibiotic, ceftriaxone, on forepaw stepping and L-DOPA-induced dyskinesia in a rodent model of Parkinson's disease. Psychopharmacology (Berl) (2014) 0.79
Does Vitamin C Influence Neurodegenerative Diseases and Psychiatric Disorders? Nutrients (2017) 0.75
Glutamate uptake. Prog Neurobiol (2001) 13.59
Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell (1996) 12.59
The functional anatomy of basal ganglia disorders. Trends Neurosci (1989) 12.28
Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol (1985) 7.93
Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature (2005) 7.19
Bursts as a unit of neural information: making unreliable synapses reliable. Trends Neurosci (1997) 5.87
Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse. Nat Neurosci (2003) 4.63
Striatal plasticity and basal ganglia circuit function. Neuron (2008) 3.89
Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. Proc Natl Acad Sci U S A (2004) 3.73
Vitamin C as an antioxidant: evaluation of its role in disease prevention. J Am Coll Nutr (2003) 3.34
Vitamin E: function and metabolism. FASEB J (1999) 3.21
The origins of two-state spontaneous membrane potential fluctuations of neostriatal spiny neurons. J Neurosci (1996) 3.20
Oscillatory entrainment of striatal neurons in freely moving rats. Neuron (2004) 3.11
Huntingtin-interacting protein HIP14 is a palmitoyl transferase involved in palmitoylation and trafficking of multiple neuronal proteins. Neuron (2004) 3.04
Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins. J Biol Chem (1999) 2.96
Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sci U S A (1988) 2.78
Start/stop signals emerge in nigrostriatal circuits during sequence learning. Nature (2010) 2.76
Protein palmitoylation in neuronal development and synaptic plasticity. Nat Rev Neurosci (2010) 2.66
Ceftriaxone restores glutamate homeostasis and prevents relapse to cocaine seeking. Biol Psychiatry (2010) 2.60
Ascorbate regulation and its neuroprotective role in the brain. Trends Neurosci (2000) 2.36
Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington's disease phenotype in the R6/2 mouse. Neuroscience (2008) 2.31
Bursts as a unit of neural information: selective communication via resonance. Trends Neurosci (2003) 2.23
Palmitoylation of huntingtin by HIP14 is essential for its trafficking and function. Nat Neurosci (2006) 2.19
Huntington's disease: a clinical review. Orphanet J Rare Dis (2010) 2.12
The corticostriatal pathway in Huntington's disease. Prog Neurobiol (2006) 1.99
Vitamin C function in the brain: vital role of the ascorbate transporter SVCT2. Free Radic Biol Med (2009) 1.94
Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice. J Neurophysiol (2001) 1.91
Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms. Proc Natl Acad Sci U S A (2009) 1.87
Glutamate transporters in neurologic disease. Arch Neurol (2001) 1.80
NMDA receptor function in mouse models of Huntington disease. J Neurosci Res (2001) 1.76
Impaired glutamate uptake in the R6 Huntington's disease transgenic mice. Neurobiol Dis (2001) 1.71
Huntington's disease: can mice lead the way to treatment? Neuron (2011) 1.71
Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation. Brain (2002) 1.71
Differential compartmentalization of brain ascorbate and glutathione between neurons and glia. Neuroscience (1998) 1.70
Delaying the onset of Huntington's in mice. Nature (2000) 1.69
The biochemical functions of ascorbic acid. Annu Rev Nutr (1986) 1.68
SVCT1 and SVCT2: key proteins for vitamin C uptake. Amino Acids (2007) 1.67
Induction of Nrf2 and xCT are involved in the action of the neuroprotective antibiotic ceftriaxone in vitro. J Neurochem (2009) 1.63
Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function. Neuroscience (2011) 1.62
Early synaptic pathophysiology in neurodegeneration: insights from Huntington's disease. Trends Neurosci (2010) 1.62
Dopaminergic modulation of glutamate-induced excitations of neurons in the neostriatum and nucleus accumbens of awake, unrestrained rats. J Neurophysiol (1996) 1.55
Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's disease. J Neurosci (2001) 1.52
Enhanced sensitivity to N-methyl-D-aspartate receptor activation in transgenic and knockin mouse models of Huntington's disease. J Neurosci Res (1999) 1.48
Probing brain chemistry with electroanalytical techniques. Anal Chem (1976) 1.44
Neurochemical changes in Huntington R6/2 mouse striatum detected by in vivo 1H NMR spectroscopy. J Neurochem (2007) 1.38
A vitamin as neuromodulator: ascorbate release into the extracellular fluid of the brain regulates dopaminergic and glutamatergic transmission. Prog Neurobiol (1994) 1.35
In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects. Hum Mol Genet (2010) 1.34
Alterations in cortical excitation and inhibition in genetic mouse models of Huntington's disease. J Neurosci (2009) 1.28
Mechanisms of oxidative glutamate toxicity: the glutamate/cystine antiporter system xc- as a neuroprotective drug target. CNS Neurol Disord Drug Targets (2010) 1.28
Dysregulated information processing by medium spiny neurons in striatum of freely behaving mouse models of Huntington's disease. J Neurophysiol (2008) 1.28
Corticostriatal synaptic function in mouse models of Huntington's disease: early effects of huntingtin repeat length and protein load. J Physiol (2007) 1.27
The concentrations and distributions of three C-terminal variants of the GLT1 (EAAT2; slc1a2) glutamate transporter protein in rat brain tissue suggest differential regulation. Neuroscience (2009) 1.27
Hyperactive striatal neurons in symptomatic Huntington R6/2 mice: variations with behavioral state and repeated ascorbate treatment. Neuroscience (2005) 1.24
Ascorbic acid in the brain. Brain Res Brain Res Rev (1993) 1.23
Altered information processing in the prefrontal cortex of Huntington's disease mouse models. J Neurosci (2008) 1.18
Ascorbate treatment attenuates the Huntington behavioral phenotype in mice. Neuroreport (2003) 1.16
Mitotic stability and meiotic variability of the (CAG)n repeat in the Huntington disease gene. Hum Mol Genet (1993) 1.15
Striatal neuronal activity and responsiveness to dopamine and glutamate after selective blockade of D1 and D2 dopamine receptors in freely moving rats. J Neurosci (1999) 1.11
Glutamate uptake is reduced in prefrontal cortex in Huntington's disease. Neurochem Res (2007) 1.10
Sex differences in behavior and striatal ascorbate release in the 140 CAG knock-in mouse model of Huntington's disease. Behav Brain Res (2007) 1.09
Progressive synaptic pathology of motor cortical neurons in a BAC transgenic mouse model of Huntington's disease. Neuroscience (2008) 1.08
Small changes, big impact: posttranslational modifications and function of huntingtin in Huntington disease. Neuroscientist (2011) 1.08
What have we learned from gene expression profiles in Huntington's disease? Neurobiol Dis (2011) 1.05
Genetic mouse models of Huntington's disease: focus on electrophysiological mechanisms. ASN Neuro (2010) 1.03
Regulation of the NMDA receptor by redox phenomena: inhibitory role of ascorbate. Brain Res (1990) 1.03
Corticostriatal dysfunction and glutamate transporter 1 (GLT1) in Huntington's disease: interactions between neurons and astrocytes. Basal Ganglia (2012) 1.02
Mouse models of Huntington disease: variations on a theme. Dis Model Mech (2009) 1.02
Neuronal and glial glutamate transporters possess an SH-based redox regulatory mechanism. Eur J Neurosci (1997) 1.00
Altered striatal amino acid neurotransmitter release monitored using microdialysis in R6/1 Huntington transgenic mice. Eur J Neurosci (2001) 1.00
Glutamate toxicity in the striatum of the R6/2 Huntington's disease transgenic mice is age-dependent and correlates with decreased levels of glutamate transporters. Neurobiol Dis (2009) 0.99
Extracellular ascorbate modulates glutamate dynamics: role of behavioral activation. BMC Neurosci (2007) 0.99
Palmitoylation and function of glial glutamate transporter-1 is reduced in the YAC128 mouse model of Huntington disease. Neurobiol Dis (2010) 0.99
Force-plate quantification of progressive behavioral deficits in the R6/2 mouse model of Huntington's disease. Behav Brain Res (2009) 0.99
Dysregulated Neuronal Activity Patterns Implicate Corticostriatal Circuit Dysfunction in Multiple Rodent Models of Huntington's Disease. Front Syst Neurosci (2011) 0.98
Immunohistochemical study of the distribution of sodium-dependent vitamin C transporters in adult rat brain. J Neurosci Res (2006) 0.98
Dysregulation of ascorbate release in the striatum of behaving mice expressing the Huntington's disease gene. J Neurosci (2002) 0.97
Glutamate stimulates ascorbate transport by astrocytes. Brain Res (2000) 0.95
"Brain training" improves cognitive performance and survival in a transgenic mouse model of Huntington's disease. Neurobiol Dis (2011) 0.94
Altered neural and behavioral dynamics in Huntington's disease: an entropy conservation approach. PLoS One (2012) 0.93
Changes in striatal procedural memory coding correlate with learning deficits in a mouse model of Huntington disease. Proc Natl Acad Sci U S A (2011) 0.93
Investigating striatal function through cell-type-specific manipulations. Neuroscience (2011) 0.92
Diminished activity-dependent brain-derived neurotrophic factor expression underlies cortical neuron microcircuit hypoconnectivity resulting from exposure to mutant huntingtin fragments. J Pharmacol Exp Ther (2010) 0.91
Iontophoresis in the neostriatum of awake, unrestrained rats: differential effects of dopamine, glutamate and ascorbate on motor- and nonmotor-related neurons. Neuroscience (1995) 0.91
Dysfunctional behavioral modulation of corticostriatal communication in the R6/2 mouse model of Huntington's disease. PLoS One (2012) 0.91
Regional distribution of ascorbate and 3,4-dihydroxyphenylacetic acid (DOPAC) in rat striatum. Brain Res (1991) 0.90
Vitamin C distribution and retention in the mouse brain. Brain Res (2010) 0.89
The vitamin C transporter SVCT2 is expressed by astrocytes in culture but not in situ. Neuroreport (2000) 0.89
Synaptic plasticity and self-organization in the hippocampus. Nat Neurosci (2005) 0.88
Extracellular ascorbate modulates cortically evoked glutamate dynamics in rat striatum. Neurosci Lett (2005) 0.88
Detailed mapping of ascorbate distribution in rat brain. Neurosci Lett (1982) 0.87
Release of ascorbate from a synaptosomal fraction of rat brain. Neurochem Int (1984) 0.87
Behavioral activation in rats requires endogenous ascorbate release in striatum. J Neurosci (2001) 0.87
Circadian changes in extracellular ascorbate in rat cortex, accumbens, striatum and hippocampus: correlations with motor activity. Neurosci Lett (1985) 0.86
Voltammetry in the striatum of chronic freely moving rats: detection of catechols and ascorbic acid. Brain Res (1981) 0.86
Corticostriatal dysfunction underlies diminished striatal ascorbate release in the R6/2 mouse model of Huntington's disease. Brain Res (2009) 0.85
Ascorbate modulates glutamate-induced excitations of striatal neurons. Brain Res (1998) 0.85
The dorsomedial striatum mediates flexible choice behavior in spatial tasks. Behav Brain Res (2011) 0.83
Dynamic changes in extracellular fluid ascorbic acid monitored by in vivo electrochemistry. Brain Res (1991) 0.83
Simultaneous electrochemical and unit recording measurements: characterization of the effects of D-amphetamine and ascorbic acid on neostriatal neurons. Brain Res (1983) 0.83